KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Sarepta Therapeutics (SRPT) Interest & Investment Income: 2012-2022

Historic Interest & Investment Income for Sarepta Therapeutics (SRPT) over the last 6 years, with Dec 2022 value amounting to $9.1 million.

  • Sarepta Therapeutics' Interest & Investment Income rose 9506.32% to $9.1 million in Q4 2022 from the same period last year, while for Dec 2022 it was $16.5 million, marking a year-over-year increase of 4557.63%. This contributed to the annual value of $36.3 million for FY2023, which is 119.90% up from last year.
  • Sarepta Therapeutics' Interest & Investment Income amounted to $9.1 million in Q4 2022, which was up 90.92% from $4.8 million recorded in Q3 2022.
  • In the past 5 years, Sarepta Therapeutics' Interest & Investment Income ranged from a high of $9.1 million in Q4 2022 and a low of -$7.0 million during Q3 2018.
  • In the last 3 years, Sarepta Therapeutics' Interest & Investment Income had a median value of $160,500 in 2021 and averaged $1.7 million.
  • Per our database at Business Quant, Sarepta Therapeutics' Interest & Investment Income crashed by 3,886.96% in 2018 and then spiked by 9,506.32% in 2022.
  • Over the past 5 years, Sarepta Therapeutics' Interest & Investment Income (Quarterly) stood at -$2.3 million in 2018, then surged by 164.04% to $1.5 million in 2019, then slumped by 95.20% to $71,000 in 2020, then surged by 33.80% to $95,000 in 2021, then skyrocketed by 9,506.32% to $9.1 million in 2022.
  • Its Interest & Investment Income was $9.1 million in Q4 2022, compared to $4.8 million in Q3 2022 and $2.4 million in Q2 2022.